4
Changes in Ownership
Oruka Therapeutics, Inc. Filed Acc 0001209191-17-025619
Chief Operating Officer sold 390 shares at $2.41 ($940)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Keuer Thomas A Chief Operating Officer | 2017-04-04 | Sale | −390 | $2.41 | $940 | 14,045 | D |
| Open-market sales · 390 sh · avg $2.41 · $940 | |||||||
Loading xslF345X03/doc4.xml…